Who owns Repare Therapeutics Ord?
- Ticker: RPTX
- CUSIP Number: 760273102
Tip: Access positions for across all investors
Analyze quarterly positions in Repare Therapeutics Ord with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Repare Therapeutics Ord stock
Who bought or sold Repare Therapeutics Ord this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| BVF | 10M | $49M | 0% | Mar 2024 |
|
| OrbiMed Advisors | 3.3M | $16M | 0% | Mar 2024 |
|
| Blue Owl Capital Holdings | 3.1M | $15M | 0% | Mar 2024 |
|
| ARK Investment Management | 2.7M | $13M | -4% | Mar 2024 |
|
| Versant Venture Management | 2.6M | $13M | 0% | Mar 2024 |
|
| MPM Asset Management | 2.2M | $11M | 0% | Mar 2024 |
|
| Redmile Group | 2.0M | $9.5M | -6% | Mar 2024 |
|
| MPM Oncology Impact Management | 1.6M | $7.7M | 0% | Mar 2024 |
|
| Artal Group | 700k | $3.3M | 0% | Mar 2024 |
|
| Aquilo Capital Management | 633k | $3.0M | 0% | Mar 2024 |
|
| Ensign Peak Advisors | 344k | $1.6M | 0% | Mar 2024 |
|
| Sumitomo Mitsui Trust Holdings | 308k | $1.5M | -5% | Mar 2024 |
|
| Nikko Asset Management Americas | 308k | $1.4M | -5% | Mar 2024 |
|
| Morgan Stanley | 288k | $1.4M | 471% | Mar 2024 |
|
| Millennium Management | 169k | $795k | -7% | Mar 2024 |
|
| HighVista Strategies | 165k | $778k | 0% | Mar 2024 |
|
| Acadian Asset Management | 134k | $625k | 64% | Mar 2024 |
|
| GSA Capital Partners | 126k | $594k | -13% | Mar 2024 |
|
| D. E. Shaw & Co | 120k | $566k | 56% | Mar 2024 |
|
| Bank Of Montreal | 105k | $510k | 0% | Mar 2024 |
|
| Citadel Advisors | 73k | $345k | 1% | Mar 2024 |
|
| Opaleye Management | 68k | $318k | 100% | Mar 2024 |
|
| Two Sigma Investments | 67k | $314k | 162% | Mar 2024 |
|
| BlackRock | 61k | $289k | -82% | Mar 2024 |
|
| Harbor Capital Advisors | 61k | $286k | 26% | Mar 2024 |
|
| Vanguard Group | 56k | $263k | -11% | Mar 2024 |
|
| Exchange Traded Concepts | 55k | $257k | 302% | Mar 2024 |
|
| Corton Capital | 46k | $218k | 66% | Mar 2024 |
|
| Dimensional Fund Advisors | 41k | $192k | -7% | Mar 2024 |
|
| Jump Financial | 40k | $289k | 100% | Dec 2023 |
|
| Goldman Sachs Group | 36k | $171k | 25% | Mar 2024 |
|
| Cubist Systematic Strategies | 35k | $167k | 33% | Mar 2024 |
|
| American Century Companies | 32k | $153k | 81% | Mar 2024 |
|
| Stifel Financial | 30k | $143k | 100% | Mar 2024 |
|
| PDT Partners | 30k | $142k | 100% | Mar 2024 |
|
| Susquehanna International | 27k | $128k | -91% | Mar 2024 |
|
| Squarepoint Ops | 27k | $127k | -50% | Mar 2024 |
|
| Geode Capital Management | 27k | $125k | 0% | Mar 2024 |
|
| Blackstone Group | 26k | $122k | 0% | Mar 2024 |
|
| Connor, Clark & Lunn Investment Management | 26k | $122k | 54% | Mar 2024 |
|
| Bank of America Corporation | 23k | $108k | 6% | Mar 2024 |
|
| ExodusPoint Capital Management | 21k | $99k | 100% | Mar 2024 |
|
| Oracle Alpha | 20k | $92k | 59% | Mar 2024 |
|
| Jane Street | 17k | $80k | -40% | Mar 2024 |
|
| Occudo Quantitative Strategies | 15k | $73k | -50% | Mar 2024 |
|
| Vontobel Holding | 15k | $71k | 0% | Mar 2024 |
|
| Compagnie Lombard, Odier SCA | 14k | $66k | 0% | Mar 2024 |
|
| Two Sigma Advisers | 12k | $55k | 100% | Mar 2024 |
|
| Brevan Howard Capital Management | 11k | $52k | -30% | Mar 2024 |
|
| CIBC World Markets | 11k | $49k | 100% | Mar 2024 |
|
| SRS Capital Advisors | 10k | $73k | 100% | Dec 2023 |
|
| Group One Trading | 7.6k | $36k | -42% | Mar 2024 |
|
| Simplex Trading | 5.3k | $24k | -50% | Mar 2024 |
|
| Tower Research Capital | 4.0k | $19k | -35% | Mar 2024 |
|
| Lazard Asset Management | 3.0k | $0 | -70% | Dec 2023 |
|
| Quantbot Technologies | 2.0k | $9.6k | 100% | Mar 2024 |
|
| National Bank Of Canada /fi/ | 1.6k | $12k | -11% | Dec 2023 |
|
| New York State Common Retirement Fund | 1.3k | $6.0k | 0% | Mar 2024 |
|
| TD Waterhouse Canada | 1.3k | $5.4k | 0% | Mar 2024 |
|
| Wells Fargo & Company | 1.1k | $5.4k | -3% | Mar 2024 |
|
| Federation des caisses Desjardins du Quebec | 1.1k | $5.2k | 100% | Mar 2024 |
|
| Qube Research & Technologies | 978.00 | $4.6k | 100% | Mar 2024 |
|
| Barclays | 530.00 | $2.0k | 0% | Mar 2024 |
|
| UBS Group | 518.00 | $2.4k | 7300% | Mar 2024 |
|
| Royal Bank of Canada | 285.00 | $0 | -72% | Mar 2024 |
|
| Citigroup | 34.00 | $160.000600 | 0% | Mar 2024 |
|
| Jpmorgan Chase & Co | 4.00 | $19.000000 | 0% | Mar 2024 |
|
Who sold out of Repare Therapeutics Ord?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| T. Rowe Price Investment Management | Sep 2023 | 1.8M | $22M |
| FMR | Sep 2023 | 1.1M | $13M |
| Logos Global Management | Dec 2023 | 600k | $4.4M |
| Sio Capital Management | Sep 2023 | 76k | $919k |
| Algert Coldiron Investors | Sep 2023 | 31k | $371k |
| Trexquant Investment | Sep 2023 | 30k | $356k |
| Marshall Wace | Dec 2023 | 27k | $196k |
| Belvedere Trading | Sep 2023 | 19k | $228k |
| California State Teachers Retirement System | Sep 2023 | 17k | $202k |
| Northern Trust | Sep 2023 | 15k | $178k |
| Legal & General Group | Dec 2023 | 706.00 | $5.2k |